Milestone Scientific (MLSS) 2.8000 $MLSS
Milestone Scientific Reports First Quarter 2015 Financial Results and Provides Business Update
Marketwired - Thu May 14, 6:02PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the first quarter ended March 31, 2015 and provided a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary"
.
Milestone Scientific Schedules First Quarter 2015 Earnings Conference Call
Marketwired - Thu May 14, 12:17PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 AM Eastern Daylight Savings Time on Friday, May 15, 2015 to discuss the Company's financial results for the first quarter ended March 31, 2015, as well as the Company's corporate progress and other developments.
Milestone Scientific Provides Update on U.S. Clinical Trials for Epidural Instrument
Marketwired - Tue Apr 21, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided an update on its Epidural & IA Subsidiary, which, as previously announced, has commenced its pivotal Investigational Device Exemption (IDE) clinical trial in the U.S. with the aim of verifying the placement of the epidural needle tip in the lumbar epidural space, and that three prominent university and pain management sites in the United States have received Institutional Review Board approvals. The company further announced the clinical trial for the company's epidural instrument has reached an enrollment of 100 patients. The goal of the pivotal IDE clinical trial is to demonstrate the safety and efficacy of the epidural instrument.
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 1.80 (-0.01), WGBS: 3.75 (-0.05), AFFX: 12.50 (+0.03), ABAX: 52.80 (+0.06)
Milestone Scientific Reports Fourth Quarter and 2014 Financial Results
Marketwired - Wed Apr 01, 6:00AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the fourth quarter and year ended December 31, 2014, as well as a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary" .
Milestone Scientific Signs Letter of Intent With MILA International to Market and Distribute a Novel Instrument for Equine Maxillary Nerve Blocks
Marketwired - Tue Mar 31, 10:45AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has signed a letter of intent with Kentucky-based MILA International Inc., a global marketer and distributor of veterinary products, to collaborate on the development, commercialization and distribution of an anesthetic delivery instrument for maxillary nerve block procedures in horses. The initial research and clinical validation will be conducted by Dr. Luis Campoy at Cornell University College of Veterinary Medicine.
Milestone Scientific Schedules Fourth Quarter 2014 Earnings Conference Call
Marketwired - Mon Mar 30, 1:39PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2015 to discuss the Company's financial results for the fourth quarter ended December 31, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific Provides Business Update Regarding Launch of New Medical Instruments
Marketwired - Mon Feb 09, 8:43AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided a business update on the status of its new medical instruments based on Milestone's computer-controlled injection and drug delivery technology. These new medical instruments represent an alternative to the syringe and are designed to provide cost reductions, safe, controlled painless injections.
Milestone Scientific to Present at The Brewer Group Innovations Conference
Marketwired - Fri Feb 06, 7:11AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Monday, February 9th at 11:00 a.m. EST at The Brewer Group Innovations Conference. The conference is being held at the Mondrian South Beach in Miami, Florida.
Milestone Scientific Announces Distribution Agreement for Intra-Articular Instrument in China
Marketwired - Mon Dec 22, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its intra-articular instrument to be used in the treatment of osteoarthritis. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases annually following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 300 instruments; year two is 600 instruments and year three is 800 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States. Although companies have no control over the regulatory process, Milestone currently believes it will have approval by the end of the second quarter of 2015.
Milestone Scientific Appoints Steven F. Robins as President of Milestone Scientific and Milestone Medical
Marketwired - Tue Dec 16, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins as President of Milestone Scientific and Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments.
JNJ: 102.92 (+0.62)
Milestone Scientific Reports First Quarter 2015 Financial Results and Provides Business Update
Marketwired - Thu May 14, 6:02PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the first quarter ended March 31, 2015 and provided a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary"
. Milestone Scientific Schedules First Quarter 2015 Earnings Conference Call
Marketwired - Thu May 14, 12:17PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 AM Eastern Daylight Savings Time on Friday, May 15, 2015 to discuss the Company's financial results for the first quarter ended March 31, 2015, as well as the Company's corporate progress and other developments.
Milestone Scientific Provides Update on U.S. Clinical Trials for Epidural Instrument
Marketwired - Tue Apr 21, 6:30AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided an update on its Epidural & IA Subsidiary, which, as previously announced, has commenced its pivotal Investigational Device Exemption (IDE) clinical trial in the U.S. with the aim of verifying the placement of the epidural needle tip in the lumbar epidural space, and that three prominent university and pain management sites in the United States have received Institutional Review Board approvals. The company further announced the clinical trial for the company's epidural instrument has reached an enrollment of 100 patients. The goal of the pivotal IDE clinical trial is to demonstrate the safety and efficacy of the epidural instrument.
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 1.80 (-0.01), WGBS: 3.75 (-0.05), AFFX: 12.50 (+0.03), ABAX: 52.80 (+0.06)
Milestone Scientific Reports Fourth Quarter and 2014 Financial Results
Marketwired - Wed Apr 01, 6:00AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced financial results for the fourth quarter and year ended December 31, 2014, as well as a business update including its minority owned subsidiary which holds the exclusive rights to the epidural and intra-articular (IA) instruments ("Epidural & IA Subsidiary"
. Milestone Scientific Signs Letter of Intent With MILA International to Market and Distribute a Novel Instrument for Equine Maxillary Nerve Blocks
Marketwired - Tue Mar 31, 10:45AM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it has signed a letter of intent with Kentucky-based MILA International Inc., a global marketer and distributor of veterinary products, to collaborate on the development, commercialization and distribution of an anesthetic delivery instrument for maxillary nerve block procedures in horses. The initial research and clinical validation will be conducted by Dr. Luis Campoy at Cornell University College of Veterinary Medicine.
Milestone Scientific Schedules Fourth Quarter 2014 Earnings Conference Call
Marketwired - Mon Mar 30, 1:39PM CDT
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2015 to discuss the Company's financial results for the fourth quarter ended December 31, 2014, as well as the Company's corporate progress and other developments.
Milestone Scientific Provides Business Update Regarding Launch of New Medical Instruments
Marketwired - Mon Feb 09, 8:43AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today provided a business update on the status of its new medical instruments based on Milestone's computer-controlled injection and drug delivery technology. These new medical instruments represent an alternative to the syringe and are designed to provide cost reductions, safe, controlled painless injections.
Milestone Scientific to Present at The Brewer Group Innovations Conference
Marketwired - Fri Feb 06, 7:11AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present on Monday, February 9th at 11:00 a.m. EST at The Brewer Group Innovations Conference. The conference is being held at the Mondrian South Beach in Miami, Florida.
Milestone Scientific Announces Distribution Agreement for Intra-Articular Instrument in China
Marketwired - Mon Dec 22, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that through its minority owned subsidiary, Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments, it has entered into a distribution agreement with Milestone China for its intra-articular instrument to be used in the treatment of osteoarthritis. Milestone China will oversee sales and distribution of the instrument in China and other parts of Asia. Under the agreement, Milestone China has agreed to certain minimum purchases annually following CFDA marketing clearance as a condition of the distribution agreement. Year one minimum purchase is 300 instruments; year two is 600 instruments and year three is 800 instruments. CFDA marketing clearance can be sought only following FDA marketing clearance in the United States. Although companies have no control over the regulatory process, Milestone currently believes it will have approval by the end of the second quarter of 2015.
Milestone Scientific Appoints Steven F. Robins as President of Milestone Scientific and Milestone Medical
Marketwired - Tue Dec 16, 7:30AM CST
Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins as President of Milestone Scientific and Milestone Medical, exclusive licensee of Milestone Scientific's epidural and intra-articular instruments.
JNJ: 102.92 (+0.62)
